Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06515496

A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.

This study evaluates the efficacy of Scale Media's HLV Clinical Formula Hair Vitamins on the health and appearance of hair, focusing on growth, volume, dullness, overall health, hair shedding, fullness, and strength. It is a randomized controlled trial with 50 female-at-birth participants experiencing self-perceived hair thinning.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Hair Thinning Alopecia Hair Diseases Hair Shedding Hypotrichosis Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

35 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Santa Monica, California, 90404, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female at birth, aged 35+.
  • Self-perceived hair thinning and increased hair shedding for at least three months.
  • Consistent hair care routine for at least one month prior.
  • Willing to maintain hair care routine, diet, and refrain from new vitamins or supplements targeting hair growth during the study.
  • Generally healthy without uncontrolled chronic diseases.

Exclusion criteria

  • Hair loss conditions other than female pattern baldness.
  • Pregnant, breastfeeding, or trying to conceive.
  • Currently taking iron supplements or other hair growth treatments.
  • Significant chronic conditions or planned medical procedures that interfere with protocol adherence.
  • Recent chemical hair treatments or plans for such treatments during the study.
  • Severe allergic reactions to the product's ingredients.
  • Recent surgeries, major illnesses, or undergoing chemotherapy/radiotherapy.

Treatment and study plan

Scale HLV Clinical Formula Hair Vitamins

Dietary Supplement

For the first week, participants will take 1 capsule in the morning and 2 capsules in the evening before food. From Week 2 onwards, participants will take 3 capsules daily in the evening before food.

Placebo

Other

For the first week, participants will take 1 capsule in the morning and 2 capsules in the evening before food. From Week 2 onwards, participants will take 3 capsules daily in the evening before food.

Primary outcomes

  1. Reduction in Hair Shedding

    Time frame: Baseline, Day 90, and Day 180

    Hair shedding will be measured through hair counts from the at-home comb test and hair health will be evaluated through expert dermatologist grading based on photos provided by participants.

Secondary outcomes

  1. Improvement in Hair Health Perception

    Time frame: Baseline, Day 30, Day 60, Day 90, Day 120, Day 150, and Day 180

    Participants' perceptions of the product's effect on overall hair health, including volume, dullness, fullness, and strength, will be evaluated through self-reported questionnaires.

Sponsors and collaborators

Lead sponsor

Scale Media Inc

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jul 23, 2024
Registry last updated
Jul 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.